Publications by authors named "A A Piper"

Background: Non-invasive ventilation (NIV) uses positive pressure to assist people with respiratory muscle weakness or severe respiratory compromise to breathe. Most people use this treatment during sleep when breathing is most susceptible to instability. The benefits of using NIV in motor neurone disease (MND) are well-established.

View Article and Find Full Text PDF

Recommendations released by the CDC in 2023 address the need to demonstrate that the RNA genome of positive-strand RNA viruses is inactivated in addition to viral particles. This recommendation is in response to the similarities between host mRNA and the viral genome that allow the viral RNA to be used as a template by host replication mechanisms to produce infectious viruses; therefore, there is concern that through artificial introduction into host cells, active positive-strand RNA genomes can be utilized to produce infectious viruses out of a containment facility. Utilizing 10% formalin for 7 days or 2.

View Article and Find Full Text PDF

Thread-based microfluidics, which rely on capillary forces in threads for liquid flow, are a promising alternative to conventional microfluidics, as they can be easily integrated into wearable textile-based biosensors. We present here advanced textile-based microfluidic devices fabricated by machine stitching, using only commercially available textiles. We stitch a polyester "Coolmax®" yarn with enhanced wicking abilities into both hydrophobic fabric and hydrophobically treated stretchable fabric, that serve as non-wicking substrates.

View Article and Find Full Text PDF

Currently, evidence-based guidelines about cleaning positive airway pressure devices for maintenance or reprocessing for a new user do not exist. There is no strong evidence of harm caused by contaminated positive airway pressure equipment. Future research opportunities exist to streamline cleaning processes, assure hygiene, and reduce waste.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with COPD/OSA overlap syndrome (OVS) have a better prognosis than those with COPD alone, especially in stable outpatients.
  • In a study of 168 patients, those with OVS showed improved median survival rates and lower mortality, particularly when discharged with home positive airway pressure (PAP) therapy.
  • Although the initial analysis indicated significant differences in mortality rates favoring OVS, further adjustments suggest that the difference may not be statistically conclusive after accounting for confounders.
View Article and Find Full Text PDF